Key result
IVUS-guided PCI cuts major cardiovascular events ~40% vs. angiography-guided PCI in unprotected left main disease.
Why the study?
The clinical impact of intravascular ultrasound guidance versus angiography guidance in PCI for unprotected left main coronary artery disease remains uncertain and requires comprehensive evaluation.
Does IVUS-guided PCI reduce MACE in patients with unprotected left main coronary artery disease compared to angiography-guided PCI?
Meta-Analysis (n=15,370)
Does IVUS-guided PCI reduce MACE in patients with unprotected left main coronary artery disease compared to angiography-guided PCI?
Answers are grounded in this paper and cite their sources.
IVUS-guided PCI significantly reduces the risk of MACE, mortality, and other adverse cardiovascular events compared to angiography-guided PCI in patients with unprotected left main coronary artery disease.
The unprotected left main coronary artery (ULMCA) disease is regarded as the highest-risk lesion subset of coronary artery disease (CAD). It is linked to significantly higher risks of cardiovascular morbidity and mortality when compared to other obstructive CAD. It has a mortality rate of up to 50% on a 3-year follow-up if left untreated [1]. For individuals with unprotected LMCA disease, the conventional revascularization method
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2024) conducted a meta-analysis in Unprotected left main coronary artery (ULMCA) disease (n=15,370). Intravascular ultrasound (IVUS)-guided percutaneous coronary intervention vs. Angiography-guided percutaneous coronary intervention was evaluated on Major adverse cardiovascular events (MACE) (RR 0.60, 95% CI 0.49-0.74, p=<0.01). IVUS-guided PCI reduced the risk of major adverse cardiovascular events compared to angiography-guided PCI in patients with unprotected left main coronary artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: